Selective Laser Trabeculoplasty in Phakic and Pseudophakic Eyes

Autor: M. Fran Smith, Mark Werner, J. William Doyle
Rok vydání: 2007
Předmět:
Zdroj: Ophthalmic Surgery, Lasers and Imaging Retina. 38:182-188
ISSN: 2325-8179
2325-8160
DOI: 10.3928/15428877-20070501-01
Popis: BACKGROUND AND OBJECTIVE To evaluate the effect of pseudophakia on the success of selective laser trabeculoplasty in lowering intraocular pressure (IOP). PATIENTS AND METHODS In this retrospective, nonrandomized clinical trial, a chart review of all patients who underwent selective laser trabeculoplasty from September 2002 to June 2004 using a frequency-doubled Q-switched 532-nm Nd:YAG laser was performed. Changes in IOP and statistical significance were determined at each follow-up period. Average decrease in IOP and success rates for phakic and pseudophakic eyes were compared statistically at each time period. RESULTS In the phakic group, mean IOP decreased from 18.1 to 15.5 mm Hg (P < .0005) and mean glaucoma medication use decreased from 2.1 to 1.6 medications after 24 months of follow-up. In the pseudophakic group, mean IOP decreased from 18.3 to 15.2 mm Hg (P < .005) and mean glaucoma medication use decreased from 2.2 to 1.6 medications. Success rates ranged from 54% to 67% in the phakic group and 52% to 65% in the pseudophakic group. No statistically significant difference between phakic and pseudophakic eyes in decreased IOP or success rates was seen at any time point (P > .05). No significant complications occurred in either group. CONCLUSIONS Selective laser trabeculoplasty is effective in lowering IOP in both phakic and pseudophakic patients. [Ophthalmic Surg Lasers Imaging 2007;38:182-188.] AUTHORS From the Department of Ophthalmology, University of Florida, Gainesville, Florida.Accepted for publication January 10, 2007. Presented in part at the Annual Meeting of the American Academy of Ophthalmology, New Orleans, Louisiana, October 23-26, 2004. Supported in part by an unrestricted departmental grant from Research to Prevent Blindness, Inc., New York, New York. Address correspondence to J. William Doyle, MD, PhD, University of Florida, Department of Ophthalmology, 1600 SW Archer Rd., Gainesville, FL 32610.
Databáze: OpenAIRE